The document summarizes research finding that the kinase GCN2 sustains mTORC1 suppression during amino acid deprivation by inducing the stress response protein Sestrin2. GCN2 activates the transcription factor ATF4 during amino acid starvation. ATF4 then transcriptionally upregulates Sestrin2, which is required for mTORC1 suppression. Chromatin immunoprecipitation confirms that ATF4 directly binds to the Sesn2 promoter. Sestrin2 depletion prevents mTORC1 suppression and reduces cell survival during glutamine withdrawal. Therefore, the GCN2-ATF4 pathway induces Sestrin2 to repress mTORC1 activity and promote cell survival during amino acid deprivation.
GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
Market research report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. The study includes estimations and predictions for the total global GPCR Drug targets market and also key regional markets that include North America, Europe, Asia-Pacific and Rest of World. Estimations and predictions (2005-2020) are illustrated graphically with 35 exhibits. Business profiles of 10+ major companies engaged in developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in the report. The report serves as a guide to global GPCR ?Drug Targets industry, covering more than 100 companies that are engaged in the development of GPCR Targeted Drugs, GPCR Assays Information related to recent product releases, Assay developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to GPCR Drug Targets is also provided.
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated ReceptorsAI Publications
Peroxisome proliferator-activated receptors (PPARs) was discovered in 1990 belong to the super family of steroid hormone receptors. Three subtypes of PPAR which have been identified so far- PPARα, PPARβ/δ, and PPARγ. Human peroxisome proliferator-activated receptors (hPPARs) were initially recognized as therapeutic targets for the development of drugs to treat metabolic disorders, such as diabetes and dyslipidemia but now they have been used in energy burning, dyslipidemia, diabetes, inflammation, Hepatic steatosis, liver cancer, diabetic neuropathy, atherosclerosis also. These are included in management of NIDDM, macrophage differentiation, adipose differentiation , anti-cancer, inhibition of TH2 cytokine production and rheumatoid arthritis. PPARβ/δ can use to treat Huntington’s disease, fertility, dyslipidemia. The functions of a third PPAR isoform and its potential as a therapeutic target are currently under investigation.
GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
Market research report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. The study includes estimations and predictions for the total global GPCR Drug targets market and also key regional markets that include North America, Europe, Asia-Pacific and Rest of World. Estimations and predictions (2005-2020) are illustrated graphically with 35 exhibits. Business profiles of 10+ major companies engaged in developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in the report. The report serves as a guide to global GPCR ?Drug Targets industry, covering more than 100 companies that are engaged in the development of GPCR Targeted Drugs, GPCR Assays Information related to recent product releases, Assay developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to GPCR Drug Targets is also provided.
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated ReceptorsAI Publications
Peroxisome proliferator-activated receptors (PPARs) was discovered in 1990 belong to the super family of steroid hormone receptors. Three subtypes of PPAR which have been identified so far- PPARα, PPARβ/δ, and PPARγ. Human peroxisome proliferator-activated receptors (hPPARs) were initially recognized as therapeutic targets for the development of drugs to treat metabolic disorders, such as diabetes and dyslipidemia but now they have been used in energy burning, dyslipidemia, diabetes, inflammation, Hepatic steatosis, liver cancer, diabetic neuropathy, atherosclerosis also. These are included in management of NIDDM, macrophage differentiation, adipose differentiation , anti-cancer, inhibition of TH2 cytokine production and rheumatoid arthritis. PPARβ/δ can use to treat Huntington’s disease, fertility, dyslipidemia. The functions of a third PPAR isoform and its potential as a therapeutic target are currently under investigation.
Best Event Planners To A Surprise Party To Surprise Your Loved Onesbookthecake.com
Book the cake is one of the best event planners to a surprise party organizers in Hyderabad.The guests later thank the host of the party in all praises.
Persistently normal alanine aminotransferase (PNALT) is present in 30 to 40% of chronic hepatitis patients and it is generally accepted that they have no liver damage. However, some studies suggest that there are some degrees of mild to moderate histological liver damage. We evaluated the fibrosis stage and the virological outcome in treated patients with PNALT. We collected HCV-positive patients with normal liver enzymes in a Belgian multicenter prospective randomized study between 2002 and 2006. They had fibrosis with at least F1 in Metavir score. Patients were followed for two years. They were divided in two groups. Group 1 (n=17) were patients treated by Pegylated Interferon alfa-2b (Pegintron) plus ribavirin (Rebetol). Group 2 (n=18) received no treatment and were used as a control group for 48 weeks.
Market Reports on India present the latest report on “India Kids Apparel Market”, Growing influence of media and western culture on Indian mindsets is also anticipated to fuel growth in India kids apparel market.
Teksten en liederen die geprojecteerd werden op Ten Bos op de derde zondag van de Advent. (A) 2016 (Sint Amanduskerk Erembodegem). De teksten van onze vieringen zijn te vinden op de website: http://www.kerkembodegem.be/tenbos/liturgie/vieringen.html
PI3KAktmTOR Intracellular Pathway and Breast Cancer Factors, Mechanism and Re...Dr Varruchi Sharma
The most recurrent cause of cancer-related deaths worldwide in women is the breast cancer. The key to diagnosis is early prediction and a curable stage but still treatment remains a great clinical challenge. Origin of the Problem: A number of studies have been carried out for the treatment of breast cancer which includes the targeted therapies and increased survival rates in women. Essential PI3K/mTOR signaling pathway activation has been observed in most breast cancers. The cell growth and tumor development in such cases involves phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) complex intracellular pathway. Hypothesis: Through preclinical and clinical trials, it has been observed that there are a number of other inhibitors of PI3K/Akt/mTOR pathway, which either alone or in combination with cytotoxic agents can be used for endocrine therapies. Conclusions: Structure and regulation/deregulation of mTOR provides a greater insight into the action mechanism. Also through this review, one could easily scan first and second generation inhibitors for PI3K/Akt/mTOR pathway besides targeted therapies for breast cancer and the precise role of mTOR.
Creative Biogene is a global leading agomir/ antagomir service provider for all passionate scientific researchers. And our comprehensive synthesis service is supported by Cutting-Edge Chemical Synthesis Technology. Agomir/antagomir are members of a novel class of chemically engineered oligonucleotides.
miRNAs play important roles in various cellular processes including apoptosis, cell division, and proliferation and others. Investigations of miRNAs will help to decipher protein functions and even discover new drugs. Creative Biogene is committed to providing outstanding miRNA products and comprehensive services to facilitate and simplify miRNA investigation.
https://www.creative-biogene.com/Services/MicroRNA-Agomir-Antagomir-Synthesis-Service.html
1.Receptors Link to other Enzymatic Activity.
2.Pathway of Intracellular Signal Transduction.
3.The Cyclic AMP pathway4.Cyclic GMP pathway
5.Phospholipids and Ca2+
6.The PI3-Kinase /Akt and mTOR pathways.
7.MAP Kinase Pathway.
1. GCN2 Sustains mTORC1 Suppression
Upon Amino Acid Deprivation By
Inducing Sestrin2
Ye, et al., 2015. Genes & Development
Supervisor: Dr. Moorhead
Brooke Rackel & Ahmad R. Vahab
2. Amino Acid Sensory Mechanism
Eukaryotes have 2 major regulatory mechanisms for amino acid
sensing:
1. mTORC1 signaling pathway, which is activated in the presence
of amino acids
2. GCN2 signaling pathway, which is activated by the absence of
amino acids.
16. The Kinetics Of Sestrin2 Induction Resembled Those of
an Established ATF4 Target PSAT1
17. Inhibition By Stress-Inducing Agent, Thapsigargin
Thapsigargin specifically inhibits the fusion of autophagosomes
with lysosomes; the last step in the autophagic process.
27. Chromatin Immunoprecipitation (ChIP)
DNA-binding proteins
are crosslinked to DNA
with formaldehyde in
vivo.
Isolate the chromatin.
Shear DNA along with
bound proteins into
small fragments.
Bind antibodies
specific to the DNA-
binding protein to
isolate the complex by
precipitation. Reverse
the cross-linking to
release the DNA and
digest the proteins.
Use PCR to amplify
specific DNA
sequences to see if
they were precipitated
with the antibody.
Editor's Notes
mTORC1 regulates cell growth, protein translation and metabolism by sensing oxygen and growth factors. The growth factors stimulate mTORC1 but AA are needed for full activity
When AA present, Rags GTPases along with Rheb promote the localization of mTORC1 to lysosome. When activated, mTORC1 phosphorylates ribosomal S6 kinase
(S6K), unc-51-like autophagy-activating kinase 1 (ULK1), and eIF4E-binding protein 4EBPs (eIF4E is Eukaryotic translation initiation factor involved in directing ribosomes to the cap structure of mRNAs) – 4EBPs - Family of translation repressor proteins.
mTORC1 is a major environmental sensor. It responds to a plathora of signals from various sources like amino acids, mitogens, energy stresses and hypoxia. Even if a cell has the proper energy for protein synthesis, if it does not have the amino acid building blocks for proteins, no protein synthesis will occur.
mTORC1 is a major environmental sensor. It responds to a plathora of signals from various sources like amino acids, mitogens, energy stresses and hypoxia. Even if a cell has the proper energy for protein synthesis, if it does not have the amino acid building blocks for proteins, no protein synthesis will occur.
Model for initiation of cap-dependent translation by the mTORC1–4EBP1 and mTORC1–S6K1 axes (A) In the absence of mTORC1-activating stimuli (i.e. growth factors/mitogens, amino acids and energy), hypophosphorylated 4EBP1 binds to eIF4E on the mRNA 5′-cap to suppress assembly of the pre-initiation complex. (B) In response to mTORC1-activating stimuli, mTORC1 docks to eIF3, localized at the 5′-cap, whereby it phosphorylates 4EBP1 and S6K1, inducing 4EBP1 release from eIF4E and S6K1 release from eIF3. (C) Dissociation of 4EBP1 enables eIF4G to dock to eIF4E, thus initiating assembly of the eIF4F complex (eIF4E, eIF4G and eIF4A). Upon release, S6K1 phosphorylates eIF4B, which induces eIF4B binding to eIF4A, an event that enhances eIF4A helicase activity. S6K also phosphorylates and inactivates PDCD4, which functions as an eIF4A inhibitor. (D) Assembly of these factors enables binding of the 40S ribosome and the ternary complex (eIF2, Met-tRNA and GTP) at the 5′-cap and thus formation of the pre-initiation complex (PIC) to initiate cap-dependent translation.
Sestrins are a family of proteins that are known to accumulate in cells under stressful conditions. They are highly conserved across species, but lack domain structures and their physilogical functions are not well defined.
There are 3 Sestrins expressed in mammals, all of which exhibit oxidoreductase activity, as well as inhibition of TOR.
It is known that they inhibit the Rag complex by inhibiting Rag’s upstream GAP (GTPase activating proteins) proteins, Gator1/2, which in turn disrupts mTORC1 localization to the lysosome, preventing mTORC1 from initiating transcription and translation. The mechanism of inhibition as well as the regulation of the sestrin proteins by amino acid availability is not fully understood and is one of the topics explored in this paper.
GCN2 is a Ser/Thr protein kinase that is directly responsible for sensing amino acid levels within the cell and eliciting the appropriate response.
The protein consists of 3 major domains. The first is the pseudo-kinase domain which although similar to the kinase domain lacks the catalytic residues required to phosphorylate a protein. These domains are often involved in regulating protein activity.
The second domain is the kinase domain. This is the typical protein kinase domain, ~300 aa in length and with the catalytic residues necessary to phosphorylate is substrate, in the case of GCN2, eIF2
It is an unusual protein kinase as its third domain is a histidyl-tRNA synthetase like-domain.
This domain is able to bind uncharged tRNAs in the cell. Allowing it sense the overall amino acid level.
When amino acid levels are low, uncharged tRNA’s bind to GCN2 and promote dimerization and autophosphorylation which leads to an activation of the protein.
Once activated, GCN2 is then able to phosphorylate eIF2alpha which leads to a dead end complex.
eIF2 is a GTP-binding protein with an intrinsic GTPase activity. It functions to directly initiate protein synthesis by binding Methionine charged tRNAs and carrying them to the 40s subunit of the ribosome, allowing translation to begin.
The phosphorylation of this initiation factor prevents the eIF2 protein from having GDP exchanged for GTP, which is required for its activity. This phosphorylation event ultimately leads to the prevention of global protein synthesis.
Certain genes are still able to be translated under eIF2 inhibition, including transcription factor GCN4 in yeast, or ATF4 in humans.
ATF4 allows the expression of many genes that increase amino acid metabolism.
As you can see, this pathway acts in direct opposition to the mTORC1 complex. So in this paper they explored the connection between GCN2 and mTORC1
Genetic experiments have suggested that GCN2 activation can contribute to mTORC1 inhibition following leucine depletion. repression of mTORC1 activity, as assessed by decreased S6K phosphorylation (T389), was detected within 30 min, followed by a brief recovery phase. ATF4 induction was monitored as a measure of GCN2 activity, which inversely correlated with mTORC1 activity during prolonged starvation. B) suggesting that GCN2 is required for long-term mTORC1 suppression but not short-term suppression
Sustained mTORC1 repression during leucine deprivation requires the GCN2–ATF4 pathway. (A) Immunoblots of lysates from wild-type MEFs that were cultured in leucine-free medium for up to 24 h. (B) Immunoblots of lysates from wild-type, Gcn2−/−, and Atf4−/− MEFs that were cultured in leucine-free medium for up to 24 h.
Since amino acids regulate mTORC1 activity by inducing its recruitment to lysosomal membranes, they examined whether the GCN2–ATF4 pathway was required to block lysosomal localization of mTORC1 during AAD. In wild-type MEFs cultured in full medium, mTOR was present in punctate structures that colocalized with the lysosomal membrane protein LAMP2. After 24 h of leucine starvation, mTOR was distributed throughout the cytoplasm. In contrast, in both Gcn2−/− and Atf4−/− MEFs, mTOR remained in punctate structures upon leucine starvation. Together, these data show that the GCN2–ATF4 pathway represses mTORC1 activity by inhibiting its lysosomal localization.
The lysosomal localization of mTORC1 requires the Rag GTPases, which localize to the lysosomal surface and are responsible for mTORC1 recruitment in the presence of amino acids . There is emerging evidence that members of the Sestrin family of stress response proteins are negative regulators of the Rag GTPases. B) Since Sestrins function upstream of Rag GTPases, they generated Rag A/B knockout HEK293T cells to determine whether Rag signaling is necessary for the sustained mTORC1 suppression upon leucine deprivation. In contrast to control cells, the Rag A/B knockout cells displayed sustained S6K phosphorylation even after 24 h of leucine starvation, indicating that long-term mTORC1 suppression is dependent on the Rag GTPases.
ATF4 is necessary for the transcriptional up-regulation of Sestrin2 under AAD. (A) Immunoblots of lysates from wild-type and Atf4−/− MEFs that were cultured in leucine-free medium for 0, 8, and 16 h. (B) Immunoblots of lysates from control and Rag A/B knockout HEK293T cells that were cultured in leucine-free medium for up to 24 h.
Since ATF4 is a transcription factor, they next examined whether ATF4 up-regulates Sestrin2 transcriptionally. In- deed, Sestrin2 mRNA was significantly induced during leucine deprivation in a time-dependent manner in wild- type MEFs but not in Gcn2−/− or Atf4−/− MEFs . The kinetics of Sestrin2 induction resembled those of an established ATF4 target, phosphoserine amino transferase 1 (PSAT1)
C) Quantitative PCR (qPCR) measuring mRNA expression in wild-type, Gcn2−/−, and Atf4−/− MEFs cultured in leucine-free medi- um for 0, 8, and 16 h.
To confirm that ATF4 played a direct role in Sestrin2 induction, they tested the promoter regions in response to leucine deprivation by performing ATF4- specific ChIP. They found that ATF4 was potently enriched at the Sesn2 promoter at regions that contained multiple ATF4 consensus binding sequences upon leucine deprivation. In contrast, ATF4 was not enriched at the Sesn1 promoter.
To determine whether mTORC1 suppression and Sestrin2 induction by the GCN2–ATF4 pathway were specific to leucine deprivation or general consequences of AAD, we next examined mTORC1 activity during isoleucine, lysine, or arginine withdrawal. Immunoblots of lysates from wild-type, Gcn2−/−, and Atf4−/− MEFs that were cultured in media lacking individual amino acids as indicated for 24 h. All deprivation conditions reduced mTORC1 activity significantly in wild-type MEFs. In contrast, Gcn2−/−, and Atf4−/− MEFs maintained mTORC1 activity under these starvation conditions. Withdrawal of each of these three amino acids (I, K, or R) increased Sestrin2 protein and mRNA levels in wild-type MEFs but not in Gcn2−/−, and Atf4−/− MEFs (Fig. 2D,E). These data suggest that GCN2– ATF4-dependent Sestrin2 induction and mTORC1 suppression are general consequences of AAD and are not caused by the absence of a specific amino acid
The kinetics of Sestrin2 induction resembled those of an established ATF4 target, phosphoserine amino transferase 1 (PSAT1). qPCR for measuring mRNA expression in wild-type, Gcn2−/−, and Atf4−/− MEFs that were cultured in media lacking individual amino acids as indicated for 24 h.
Thapsigargin specifically inhibits the fusion of autophagosomes with lysosomes; the last step in the autophagic process. The inhibition of the autophagic process in turn induces stress on the endoplasmic reticulum which ultimately leads to cellular death. The results indicating that GCN2-dependent Sestrin2 induction specifically responds to AAD but not other stress conditions that induce ATF4 . IB of lysates from wild type, Gcn2−/−, and Atf4−/− MEFs that were treated with 3μM thapsigargin (Tg) for up to 24 h.
Using two human cancer cell lines (HT1080 - fibrosarcoma cell line and DLD1 - colorectal adenocarcinoma) with stable expression of an ATF4 shRNA, they demonstrated that the induction of Sestrin2 upon amino acid starvation in these human cell lines also depended on ATF4. A) q-PCR for Sestrin2 expression measurement in HT1080 or DLD1 cells expressing either shRNA against ATF4 (shATF4) or a control shRNA (shNT) cultured in +/- leucine media for 24 h. PHGDH, the rate-limiting enzyme of serine synthesis, which is upregulated by the GCN2-ATF4 pathway during AAD, is used as a positive control.
In order to see if Sestrin2 was required for mTORC1 suppression during leucine withdrawl, WT or Sesn2 knockout cells were grown in the absence of leucine for up to 24h. As you can see in the blot, the KO cells were unable to suppress mTORC1 function as indicated by the presence of p-S6K. This result indicates the need for Sestrin2 for long-term mTORC1 suppression in low amino acid conditions.
In order to ensure, it was not just leucine deficiency causing these results, they repeated the experiment with Isoleucine, Lysine or Arginine lacking from the media. As you can see here in the Sesn2 KO’s, p-S6K as well as p-ULK1, anoth one of mTORC1’s substrates were present which shows that mTORC1 activity is not suppressed with out Sesn2 present. The ATF4 levels remained constant in both the WT and the KO cells which shows that ATF4 levels are not affected by Sesn2 deletion.
When looking at the localization of mTOR, you can see it remained as near the lysosome in Sesn2 KO cells, similar to those seen in the GCN2 KO cells. This is directly in contrast to the WT cells where the mTOR is not seen around the lysosomes when depleted from Leu for 24h.
Based on these results we can conclude that Sesn2 is needed for GCN2-ATF4-mediated mTORC1 suppression during amino acid deficiency.
Glutamine is a non-essential amino-acid that can activate mTORC1 through mechanisms that are different that the activation by essential amino-acids. Unlike during leucine deprivation, glutamine deprivation only repressed mTORC1 after 24h and no acute repression was observed. As we can see in the blot here, with WT cells, it took nearly 24h for mTORC1 suppression to be seen through the reduced levels of p-S6K. Explain blot.
To see whether the mTORC1 repression was through Sesn2 induction, WT, GCN2 KO and ATF4 KO cells were deprived of Glutamine for 24h.
Similar as to what was seen with Leu deprivation, during Glu deprivation, Sesn2 was induced through GCN2-ATF4 and repressed mTORC1. GCN2 and ATF4 are both required as Sesn2 was not induced in the KO cells.
GCN2-ATF4 signaling has previously been shown to promote cell-survival during Glutamine deprivation, the investigators looked at whther Sesn2 was required for cell survival when Glutamine was lacking.
Interestingly as we can see in the graph here, Sesn2 KO cells were extremely sensitive to glutamine deprivation with 80% of cells dying after 48h. This is a much greater number than the 30% seen in the WT deprived of glutamine. When looking for the apoptosis marker cleaved caspase3, it was confirmed that the cause of death in these cells was indeed apoptosis.
To further confirm that mTORC1 repression is a crucial downstream function of Sesn2, the researchers examined whether mTORC1 repression could suppress death of Sesn2 KO cells during glutamine deprivation. As you can see from the graph on the right, when rapamycin concentrations were increased to 20mM, cell death was partially rescued.
Inhibition of mTORC1 by rapamycin also reduced caspase3 activity and therefore rescued Sesn2 KO cells from cell death during glutamine deprivation. As you can see in the blot on the right here cleaved caspase is not present in the Sesn2 KO cells when deprived of glutamine and rescued by rapamycin.
Walk through blot on right.
Rapamycin inhibition of mTORC1 was also seen to rescue Gcn2 KO cells during glutamine deprivation.
Bright field images of wild type and Sesn2-/- MEFs cultured in +/- glutamine media with/without 50nM rapamycin for 48 h.
Further showing the rescue of the Sesn2 KO cells with the addition of Rapamycin.
It has been reported that Leu, Arg, and Glu are all major amino acids required for the activation of mTORC1 through various mechanisms.
The results of this study show that the deprivation of any of these amino acids results in the GCN2-dependent induction of Sesn2 in order to maintain long-term repression of mTORC1. The ability of GCN2 to become activated by uncharged tRNAs links the deficiency of amino acids to mTORC1-dpeendent translation.
Explain the model.
GCN2 senses low amino-acid levels within the cell by binding uncharged tRNAs. GCN2 then dimerizes and autophosphorylates activating the protein and allowing it to phosphorylate eIF2alpha. This phosphorylated protein activates ATF4 which leads to increased levels of transcription of Sestrin2. Sesn2 expression is then able to inhibit mTORC1 by preventing it from localizing to the lysosome through the Rag proteins.
In conclusion, this paper has found the link between the amino acid sensing function of both GCN2 and mTORC1 during amino acid starvation through the stress protein Sestrin2 , connecting some of the dots in the protein translation signaling pathway.
To confirm that ATF4 played a direct role in Sestrin2 induction, they examined a publicly available data set of genome-wide sequencing of ATF4 chromatin immunoprecipitation (ChIP). ATF4 was potently enriched at the Sesn2 promoter at regions that contained multiple ATF4 consensus binding sequences